%0
Generic
%T
Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator’s Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial
%A Larkin, James
%A Minor, David
%A D'Angelo, Sandra
%A Neyns, Bart
%A Smylie, Michael
%A Miller, Wilson H.
%A Gutzmer, Ralf
%A Linette, Gerald
%A Chmielowski, Bartosz
%A Lao, Christopher D.
%A Lorigan, Paul
%A Grossmann, Kenneth
%A Hassel, Jessica C.
%A Sznol, Mario
%A Daud, Adil
%A Sosman, Jeffrey
%A Khushalani, Nikhil
%A Schadendorf, Dirk
%A Hoeller, Christoph
%A Walker, Dana
%A Kong, George
%A Horak, Christine
%A Weber, Jeffrey
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%D 2018
%C American Society of Clinical Oncology (ASCO)